Correlation Between Molecular Partners and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Novo Nordisk AS, you can compare the effects of market volatilities on Molecular Partners and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Novo Nordisk.
Diversification Opportunities for Molecular Partners and Novo Nordisk
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Molecular and Novo is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Molecular Partners i.e., Molecular Partners and Novo Nordisk go up and down completely randomly.
Pair Corralation between Molecular Partners and Novo Nordisk
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 2.45 times more return on investment than Novo Nordisk. However, Molecular Partners is 2.45 times more volatile than Novo Nordisk AS. It trades about -0.01 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.06 per unit of risk. If you would invest 615.00 in Molecular Partners AG on August 31, 2024 and sell it today you would lose (32.00) from holding Molecular Partners AG or give up 5.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Novo Nordisk AS
Performance |
| Timeline |
| Molecular Partners |
| Novo Nordisk AS |
Molecular Partners and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Novo Nordisk
The main advantage of trading using opposite Molecular Partners and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Novo Nordisk vs. Nuvalent | Novo Nordisk vs. Arcellx | Novo Nordisk vs. Vaxcyte | Novo Nordisk vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |